SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.62 |
| Enterprise Value ($M) | 66.59 |
| Book Value ($M) | -66.74 |
| Book Value / Share | -1.21 |
| Price / Book | -0.25 |
| NCAV ($M) | -88.18 |
| NCAV / Share | -1.60 |
| Price / NCAV | -0.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.32 |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | -2.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.08 |
| Current Ratio | 1.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.18 |
| Assets | 63.62 |
| Liabilities | 130.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G | Sofinnova Investments, Inc. | 8.00 | ||
| 13G/A | Eventide Asset Management, Llc | 0.00 | -100.00 | |
| 13G/A | Prudential Financial Inc | 0.70 | -88.36 | |
| 13G/A | Jennison Associates Llc | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 5.08 | 0.00 | |
| 13G | Panacea Innovation Ltd | 9.98 | ||
| 13G/A | BlackRock, Inc. | 3.40 | -59.34 | |
| 13G | Citadel Advisors Llc | 0.40 | ||
| 13G | Tang Capital Partners Lp | 8.20 | ||
| 13G/A | Lion Point Capital, LP | 3.90 | -55.35 | |
| 13G/A | Point72 Asset Management, L.P. | 0.90 | -85.96 | |
| 13G/A | Suvretta Capital Management, Llc | 9.99 | 9.90 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 4.73 | -6.35 | |
| 13G | Franklin Resources Inc | 7.00 | 65.43 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 302,129 | 1,240,470 | 24.36 | |
| 538,289 | 1,572,946 | 34.22 | |
| 445,704 | 1,215,934 | 36.66 | |
| 546,393 | 1,628,428 | 33.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MIRM – Mirum Pharmaceuticals, Inc. | MNKD – MannKind Corporation |
| MNOV – MediciNova, Inc. | MRUS – Merus N.V. |
| MURA – Mural Oncology plc |